Publications by authors named "Yohei Oku"

Claim this Profile
T
Toxicity profile and clinical outcomes of stereotactic body radiotherapy with a focal boost without fiducials or perirectal hydrogel spacer for localized prostate cancer.
Yuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, Yousuke Aoki, Yuto Kimura, Yohei Oku

Strahlenther Onkol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy.
Yuto Kimura, Noriyuki Kadoya, Yohei Oku, Keiichi Jingu

J Radiat Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy.
Naoto Mikami, Atsuya Takeda, Aya Hashimoto, Toshiaki Takeda, Yuto Kimura, Yohei Oku

Clin Lung Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis-4N0M0 Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.
Takafumi Nemoto, Atsuya Takeda, Yukinori Matsuo, Noriko Kishi, Takahisa Eriguchi, Yohei Oku

JCO Clin Cancer Inform· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of marker-less stereotactic body radiotherapy for hepatocellular carcinoma.
Yuichi Kibe, Atsuya Takeda, Yuichiro Tsurugai, Takahisa Eriguchi, Yohei Oku

Acta Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Error detection model developed using a multi-task convolutional neural network in patient-specific quality assurance for volumetric-modulated arc therapy.
Yuto Kimura, Noriyuki Kadoya, Yohei Oku, Tomohiro Kajikawa, Seiji Tomori

Med Phys· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study.
Tomoki Kimura, Atsuya Takeda, Naoko Sanuki, Keisuke Ariyoshi, Takuhiro Yamaguchi, Yohei Oku, Masaki Kokubo

Hepatol Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal case of pancreatic panniculitis caused by occult neuroendocrine tumor in the corresponding organ: A case report and review of the published work.
Hiroshi Kasamatsu, Noritaka Oyama, Minoru Hasegawa, Yohei Oku, Genki Inoue

J Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
Tomoki Kimura, Atsuya Takeda, Yuichiro Tsurugai, Reo Kawano, Yoshiko Doi, Yohei Oku

Int J Radiat Oncol Biol Phys· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Error detection using a convolutional neural network with dose difference maps in patient-specific quality assurance for volumetric modulated arc therapy.
Yuto Kimura, Noriyuki Kadoya, Seiji Tomori, Yohei Oku, Keiichi Jingu

Phys Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for patients with non-small-cell lung cancer using RapidArc delivery and a steep dose gradient: prescription of 60% isodose line of maximum dose fitting to the planning target volume.
Yuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Yousuke Aoki, Yohei Oku

J Radiat Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy.
Atsuya Takeda, Yuichiro Tsurugai, Naoko Sanuki, Tatsuji Enomoto, Masaharu Shinkai, Yohei Oku

J Thorac Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias.
Yuichiro Tsurugai, Atsuya Takeda, Naoko Sanuki, Tatsuji Enomoto, Takeshi Kaneko, Yohei Oku

Radiother Oncol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
Takahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Yousuke Aoki, Yohei Oku

Lung Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83-100 Gy in five fractions.
Atsuya Takeda, Naoko Sanuki, Yuichiro Tsurugai, Yohei Oku, Yousuke Aoki

J Radiat Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.
Takahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, Shuichi Nishimura, Yoshiaki Takagawa, Yohei Oku

J Radiat Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma.
Naoko Sanuki, Atsuya Takeda, Yohei Oku, Takahisa Eriguchi, Shuichi Nishimura

Hepatol Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.
Yohei Oku, Atsuya Takeda, Naoko Sanuki, Yasunobu Sudo, Yoshikazu Oooka

Pract Radiat Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume.
Atsuya Takeda, Yohei Oku, Naoko Sanuki, Takahisa Eriguchi, Yousuke Aoki

J Radiat Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
Shuichi Nishimura, Atsuya Takeda, Naoko Sanuki, Satoshi Ishikura, Yohei Oku

J Thorac Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
Naoko Sanuki, Atsuya Takeda, Yohei Oku, Tomikazu Mizuno, Yosuke Aoki

Acta Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA.
Naoko Sanuki, Atsuya Takeda, Yohei Oku, Takahisa Eriguchi, Shuichi Nishimura

Int J Radiat Oncol Biol Phys· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximum standardized uptake value on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients after stereotactic body radiotherapy.
Atsuya Takeda, Naoko Sanuki, Hirofumi Fujii, Noriko Yokosuka, Shuichi Nishimura, Yohei Oku

J Thorac Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
Naoko Sanuki, Atsuya Takeda, Tomikazu Mizuno, Yohei Oku, Takahisa Eriguchi

AJR Am J Roentgenol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.
Atsuya Takeda, Naoko Sanuki, Takahisa Eriguchi, Tatsuji Enomoto, Tetsuya Yokosuka, Yohei Oku

Ann Thorac Surg· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis